ClinConnect ClinConnect Logo
Search / Trial NCT06739148

The Enhancement Effect of Low-Level Laser Therapy for Muscle Training with Combined NMES and BFR

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Dec 16, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Muscle Strength Training Low Level Laser Therapy Blood Flow Restriction Neuromuscular Electrical Stimulation

ClinConnect Summary

This clinical trial is studying the effects of combining two types of therapy—blood flow restriction training (BFR) and neuromuscular electrical stimulation (NMES)—with low-level laser therapy (LLLT) to see if it can improve muscle strength and reduce fatigue. BFR and NMES can help people with limited mobility or joint issues build muscle, but they can also lead to muscle tiredness. The researchers want to find out if using LLLT before these therapies can help improve their benefits by reducing fatigue and boosting muscle performance.

To participate in this study, you must be a healthy adult between the ages of 20 and 40, without any heart or joint diseases. You also need to have normal vision after correction (like glasses or contacts). However, if you have had a brain injury, stroke, or certain other health issues, or if you are pregnant, you won't be eligible to join. If you decide to participate, you can expect to engage in some training sessions while being monitored to see how these therapies work together. This trial is currently looking for participants, so it’s a great opportunity to contribute to research that may help others with similar conditions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Healthy adults aged 20-40, without a diagnosis of cardiovascular or neuromusculoskeletal diseases.
  • 2. Normal vision range after visual correction.
  • Exclusion Criteria:
  • 1. Exclude students who have a teacher-student relationship with the principal investigator to ensure the participants\' autonomy.
  • 2. History of brain injury, stroke, spinal cord injury, or other neuromuscular-related conditions.
  • 3. Contraindications for laser therapy: pregnancy, malignant tumor tissues, bleeding areas, and photosensitive skin regions.
  • 4. Presence of any contraindications for blood flow restriction training, such as a history of injury or strain in the non-dominant arm\'s biceps, deep vein thrombosis or venous occlusion in the non-dominant arm, acute unstable fractures in the non-dominant arm, acute regional infections in the non-dominant arm, severe peripheral arterial occlusive disease in the non-dominant arm, complete lymphatic obstruction in the non-dominant arm, and edema due to acute pulmonary edema or congestive heart failure in the non-dominant arm.

About National Cheng Kung University Hospital

National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.

Locations

Tainan, , Taiwan

Patients applied

0 patients applied

Trial Officials

Ing-Shiou Hwang, PhD

Study Chair

NCKU, Institute of Allied Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported